This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003:91:273-91.

Potential nondopaminergic drugs for Parkinson's disease

Monty A Silverdale¹, S H Fox, A R Crossman, J M Brotchie

Affiliations

PMID: 12442686

Review

Potential nondopaminergic drugs for Parkinson's disease

Monty A Silverdale et al. Adv Neurol. 2003.

. 2003:91:273-91.

Authors

Monty A Silverdale¹, S H Fox, A R Crossman, J M Brotchie

Affiliation

¹ Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.

PMID: 12442686

No abstract available

PubMed Disclaimer

Similar articles

Functional neuroanatomy of the basal ganglia in Parkinson's disease.
Wichmann T, DeLong MR. Wichmann T, et al. Adv Neurol. 2003;91:9-18. Adv Neurol. 2003. PMID: 12442660 Review. No abstract available.
Parkinson's disease is a neuropsychiatric disorder.
Agid Y, Arnulf I, Bejjani P, Bloch F, Bonnet AM, Damier P, Dubois B, François C, Houeto JL, Iacono D, Karachi C, Mesnage V, Messouak O, Vidailhet M, Welter ML, Yelnik J. Agid Y, et al. Adv Neurol. 2003;91:365-70. Adv Neurol. 2003. PMID: 12442695 Review. No abstract available.
Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.
Bezard E, Brotchie JM, Gross CE. Bezard E, et al. Nat Rev Neurosci. 2001 Aug;2(8):577-88. doi: 10.1038/35086062. Nat Rev Neurosci. 2001. PMID: 11484001 Review.
The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
Agid Y, Graybiel AM, Ruberg M, Hirsch E, Blin J, Dubois B, Javoy-Agid F. Agid Y, et al. Adv Neurol. 1990;53:83-100. Adv Neurol. 1990. PMID: 1978522 Review. No abstract available.
[Problems and future perspectives in the treatment of Parkinson's disease].
Hens L, Hellemans J. Hens L, et al. Tijdschr Gerontol Geriatr. 1982 Aug;13(4):147-54. Tijdschr Gerontol Geriatr. 1982. PMID: 6127822 Dutch.

See all similar articles

Cited by

Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway.
Pisani A, Bonsi P, Centonze D, Martorana A, Fusco F, Sancesario G, De Persis C, Bernardi G, Calabresi P. Pisani A, et al. J Neurosci. 2003 Jun 15;23(12):5272-82. doi: 10.1523/JNEUROSCI.23-12-05272.2003. J Neurosci. 2003. PMID: 12832552 Free PMC article.
Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease.
Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR. Sotnikova TD, et al. PLoS Biol. 2005 Aug;3(8):e271. doi: 10.1371/journal.pbio.0030271. Epub 2005 Aug 2. PLoS Biol. 2005. PMID: 16050778 Free PMC article.
Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.
Nyholm D. Nyholm D. Clin Pharmacokinet. 2006;45(2):109-36. doi: 10.2165/00003088-200645020-00001. Clin Pharmacokinet. 2006. PMID: 16485914 Review.
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.
Terron A, Bal-Price A, Paini A, Monnet-Tschudi F, Bennekou SH; EFSA WG EPI1 Members; Leist M, Schildknecht S. Terron A, et al. Arch Toxicol. 2018 Jan;92(1):41-82. doi: 10.1007/s00204-017-2133-4. Epub 2017 Dec 5. Arch Toxicol. 2018. PMID: 29209747 Free PMC article. Review.
Brain Functional and Structural Signatures in Parkinson's Disease.
Liu C, Jiang J, Zhou H, Zhang H, Wang M, Jiang J, Wu P, Ge J, Wang J, Ma Y, Zuo C. Liu C, et al. Front Aging Neurosci. 2020 May 26;12:125. doi: 10.3389/fnagi.2020.00125. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32528272 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information